Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Efficacy and safety of a magnesium sulfate-rich natural mineral water for patients with functional constipation.

Dupont C, Campagne A, Constant F.

Clin Gastroenterol Hepatol. 2014 Aug;12(8):1280-7. doi: 10.1016/j.cgh.2013.12.005. Epub 2013 Dec 14.

2.

Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).

Gordon M, Naidoo K, Akobeng AK, Thomas AG.

Evid Based Child Health. 2013 Jan;8(1):57-109. doi: 10.1002/ebch.1893. Review.

PMID:
23878124
3.

Efficacy and safety of a natural mineral water rich in magnesium and sulphate for bowel function: a double-blind, randomized, placebo-controlled study.

Bothe G, Coh A, Auinger A.

Eur J Nutr. 2017 Mar;56(2):491-499. doi: 10.1007/s00394-015-1094-8. Epub 2015 Nov 18.

4.

Effects of Sulfate-Rich Mineral Water on Functional Constipation: A Double-Blind, Randomized, Placebo-Controlled Study.

Naumann J, Sadaghiani C, Alt F, Huber R.

Forsch Komplementmed. 2016;23(6):356-363. doi: 10.1159/000449436. Epub 2016 Oct 12.

5.
6.

Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.

Chey WD, Lembo AJ, Lavins BJ, Shiff SJ, Kurtz CB, Currie MG, MacDougall JE, Jia XD, Shao JZ, Fitch DA, Baird MJ, Schneier HA, Johnston JM.

Am J Gastroenterol. 2012 Nov;107(11):1702-12.

PMID:
22986437
7.

Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.

Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.

Aliment Pharmacol Ther. 2005 Feb 15;21(4):435-44.

8.

Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation.

Mueller-Lissner S, Kamm MA, Wald A, Hinkel U, Koehler U, Richter E, Bubeck J.

Am J Gastroenterol. 2010 Apr;105(4):897-903. doi: 10.1038/ajg.2010.41. Epub 2010 Feb 23.

PMID:
20179697
9.

A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation.

Rao S, Lembo AJ, Shiff SJ, Lavins BJ, Currie MG, Jia XD, Shi K, MacDougall JE, Shao JZ, Eng P, Fox SM, Schneier HA, Kurtz CB, Johnston JM.

Am J Gastroenterol. 2012 Nov;107(11):1714-24; quiz p.1725.

10.

Long term efficacy, safety, and tolerabilitity of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation.

Corazziari E, Badiali D, Bazzocchi G, Bassotti G, Roselli P, Mastropaolo G, Lucà MG, Galeazzi R, Peruzzi E.

Gut. 2000 Apr;46(4):522-6.

11.

Episodic nature of symptoms in irritable bowel syndrome.

Palsson OS, Baggish J, Whitehead WE.

Am J Gastroenterol. 2014 Sep;109(9):1450-60. doi: 10.1038/ajg.2014.181. Epub 2014 Jul 1.

PMID:
24980882
13.

Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial.

Johanson JF, Wald A, Tougas G, Chey WD, Novick JS, Lembo AJ, Fordham F, Guella M, Nault B.

Clin Gastroenterol Hepatol. 2004 Sep;2(9):796-805.

PMID:
15354280
14.

The short-term effects of olive oil and flaxseed oil for the treatment of constipation in hemodialysis patients.

Ramos CI, Andrade de Lima AF, Grilli DG, Cuppari L.

J Ren Nutr. 2015 Jan;25(1):50-6. doi: 10.1053/j.jrn.2014.07.009. Epub 2014 Sep 17.

PMID:
25238699
15.
18.

The role of a probiotics mixture in the treatment of childhood constipation: a pilot study.

Bekkali NL, Bongers ME, Van den Berg MM, Liem O, Benninga MA.

Nutr J. 2007 Aug 4;6:17.

19.

Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.

Quigley EM, Vandeplassche L, Kerstens R, Ausma J.

Aliment Pharmacol Ther. 2009 Feb 1;29(3):315-28. doi: 10.1111/j.1365-2036.2008.03884.x. Epub 2008 Nov 8.

Supplemental Content

Support Center